12:00 AM
 | 
Nov 05, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Travoprost-loaded punctum plug: Phase II data

Top-line data from an open-label South African Phase II trial in 36 eyes from 20 patients with open-angle glaucoma or ocular hypertension showed that OTX-TP2 led to a reduction in mean IOP of 6.8 mmHg from baseline to day 60. Additionally, OTX-TP2 reduced mean IOP by 7.2 mmHg from baseline to day 15, by 6.6 mmHg at day 30 and by 6.7 mmHg at day 45. Mean IOP...

Read the full 317 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >